Green Valley Drug to Market SinoFresh Homeopathic Antiseptic Nasal Spray
January 03 2011 - 9:33AM
SinoFresh® HealthCare, Inc., (Pink Sheets:SFSH) is pleased to
announce that its marketing division has secured an agency
marketing relationship with Green Valley Drug,
http://www.greenvalleymed.com, the largest medical supplier in
Southern Nevada with a significant pharmacy and medical customer
base in the western U.S.
Green Valley Drug is based in a 22,000-square-foot, custom-built
facility. The facility includes a comprehensive pharmacy, a sterile
clean room and a warehouse that hubs approximately 18,000 sq.ft. of
inventory. Green Valley stocks over 2,500 different products in the
Las Vegas warehouse and can customize inventory for specific
customer needs throughout the country.
"This is a tremendous step forward for our company," states SFSH
CEO, David R. Olund. "Marketing is the key element in terms of
revenue production as we look to expand sales of our unique
premiere product, SinoFresh Homeopathic Antiseptic Nasal Spray
which targets the 37 Million sinusitis sufferers in America. Green
Valley Drug brings much to the table, supplying a wide range of
business outlets in the Western United States including independent
and cooperative pharmacies, home health agencies, dental offices,
long-term care facilities and more; everything from small practices
to large surgery centers. We are thrilled to be working with Green
Valley and having the opportunity to expand our national
distribution reach with such a paramount organization."
SinoFresh HealthCare, Inc. is a publicly traded
company (Pink Sheets:SFSH) based in Venice, Florida, that
manufactures and distributes nasal, oral and topical antiseptic
germ-killing products. SinoFresh products are marketed and
distributed globally through a network of strategic wholesale and
retail partners. SinoFresh Healthcare, Inc's, premier product,
SinoFresh Antiseptic Homeopathic Nasal spray has in laboratory
tests shown effective antiseptic capability against a variety of
pathogens such as MRSA, E-Coli, H1N1 and a broad range of other
viruses, molds, fungi and bacteria.
This press release includes forward-looking statements intended
to qualify for the safe harbor from liability established by the
Private Securities Litigation Reform Act of 1995. Our
forward-looking statements express our current expectations or
forecasts of possible future results or events, including
projections of future performance, statements of management's plans
and objectives, future contracts, and forecasts of trends and other
matters. Forward-looking statements speak only as of the date of
this filing, and we undertake no obligation to update or revise
such statements to reflect new circumstances or unanticipated
events as they occur. You can identify these statements by the fact
that they do not relate strictly to historic or current facts and
often use words such as "anticipate", "estimate", "expect",
"believe", "will likely result", "outlook", "project" and other
words and expressions of similar meaning. No assurance can be given
that the results in any forward-looking statements will be achieved
and actual results could be affected by one or more factors, which
could cause them to differ materially. For these statements, we
claim the protection of the safe harbor for forward-looking
statements contained in the Private Securities Litigation Reform
Act.
CONTACT: SinoFresh HealthCare Inc.
Investor Relations
941.375.8174 option 8